New Strategies and Best Practices in the Management of Pediatric Facial and Truncal Acne
Released On
November 14, 2022
Expires On
November 14, 2023
Media Type
Internet
Completion Time
60 minutes
Specialty
Dermatology, Pediatrics, Primary Care
Topic(s)
Pediatrics
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Annenberg Center for Health Sciences at Eisenhower.
Supported by an educational grant from Galderma.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
- Nurses — 1.0 Contact Hour
- Nurses — 1.0 CA-BRN Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity was developed for family medicine/primary care physicians, pediatricians, dermatologists, nurses, nurse practitioners, and related healthcare professionals.
Program Overview
Dermatology expert Hilary Baldwin, MD, delves into the management of pediatric facial and truncal acne addressing practical management strategies to optimize patient-centered treatment success. In addition to discussing the impact of acne on health-related quality of life and sequelae, Dr. Baldwin summarizes the pathophysiologic basis for treatment. She reviews the topical and systemic treatment options and highlights key concepts in reduction of antibiotic use, minimization of antibiotic resistance, and strategies to minimize adverse events as well as improve patient tolerability and adherence.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe the healthcare and psychological burden associated with pediatric facial and truncal acne
- Discuss new antibiotic-sparing treatment strategies for facial and truncal acne, including recent clinical data
- Create evidence-based treatment plans for pediatric patients with facial and truncal acne, considering the limitations of commonly used therapies and the inappropriate use of antibiotics
- Collaborate with pediatric patients and/or caregivers to individualize therapy for facial and truncal acne that encourages treatment adherence, manages treatment expectations, and limits sequelae
Faculty
Hilary Baldwin, MD (Presenting Faculty)
Medical Director, Acne Treatment & Research Center
Brooklyn, New York
Clinical Associate Professor of Dermatology
Rutgers Robert Wood Johnson Medical Center
New Brunswick, New Jersey
Julie Harper, MD (Contributing Faculty)
Owner, The Dermatology and Skin Care Center of Birmingham
Birmingham, Alabama
Accreditation Statement
In support of improving patient care, Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physicians:
The Annenberg Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1.0 ANCC contact hour.
Provider is approved by the California Board of Registered Nursing, Provider #13664, for 1.0 contact hour. To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Disclosures of Conflicts of Interest
It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All individuals with the potential to impact the content of an accredited education activity are expected to identify and reference off-label product use and disclose relationships with ACCME-defined ineligible companies.
The Annenberg Center assesses relevant financial relationships with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant financial relationships that are identified are mitigated by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
- Hilary Baldwin, MD
-
- Advisory Board: Almirall, Bausch, EPI, Galderma, Journey, SUN
- Speakers Bureau: Almirall, Bausch, EPI, Galderma, SUN
- Investigator: Almirall, Bausch, Galderma
- Julie Harper, MD
-
- Consultant: Almirall, Cassiopeia, Cutera, Galderma, EPI, Ortho, Sol Gel, Sun, Vyne
- Investigator: Almirall
- Speakers Bureau: Almirall, Cutera, EPI, Galderma, Ortho, Sun, Vyne
- Stock Owner: Cutera
Additional content planners
The following have no significant relationship to disclose:
Eugene Cullen, MD (Peer Reviewer)
Jessica Forster, PharmD (Medical Writer)
Amber Lea Lambert, MSN, FNP-C, DNP (Nurse Planner)
All of the financial relationships listed for these individuals have been mitigated.
Instructions for Participation and Credit
This activity is an online enduring material. Successful completion is achieved by reading and/or viewing the materials, reflecting on its implications in your practice, and completing the assessment component.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved applications.
Disclaimer
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
Contact Information
For help or questions about this activity please contact Continuing Education:
ce@annenberg.net